The U.S. Food and Drug Administration said on Thursday it approved AstraZeneca Plc's treatment for hairy cell leukemia, a slow-growing type of blood cancer.

https://ift.tt/2CRDlCI support@endlesssupplies.biz (Endless Supplies .Biz) September 13, 2018 at 01:53PM
No comments:
Post a Comment